CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Open-market sale Chief Medical Officer sold 6,097 shares at $8.30 ($50,601)
- 4 Open-market sale Chief Operating Officer sold 847 shares at $7.38 ($6,253)
- 4 Planned sale Chief Financial Officer sold 4,701 shares at $7.78 ($36,588)
- 4 Planned sale Chief Executive Officer sold 13,871 shares at $7.78 ($107,952)
- 4 Open-market sale Chief Medical Officer sold 3,285 shares at $8.09 ($26,575)
- 4 Open-market sale Chief Operating Officer sold 2,415 shares at $8.09 ($19,537)
- 4 Grant or award Chief Medical Officer acquired 28,365 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 28,082 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 28,365 shares (grant or award)
- 4 Open-market sale 10% owner sold 30,029 shares at $11.46 ($344,012)
- 4 Planned sale Chief Executive Officer sold 27,633 shares at an average $17.05 ($471,204)
- 4 Planned sale Chief Financial Officer sold 12,981 shares at $17.02 ($220,937)
- 4 Planned sale Director sold 1,060 shares at $20.50 ($21,730)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Planned sale Director sold 2,783 shares at $7.35 ($20,465)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Planned sale Director sold 1,392 shares at $7.25 ($10,096)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
- 4 Grant or award Director acquired 4,800 shares (grant or award)
Page 2 of 17 · 340 filings